Dysregulated PAD4 activity has been implicated in several autoimmune and inflammatory diseases, including type 1 diabetes mellitus (T1DM), rheumatoid arthritis, and systemic lupus erythematosus [1,2,3]. This evidence concerns the gene PADI4 and type 1 diabetes mellitus.